These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome. VandeVrede L; La Joie R; Thijssen EH; Asken BM; Vento SA; Tsuei T; Baker SL; Cobigo Y; Fonseca C; Heuer HW; Kramer JH; Ljubenkov PA; Rabinovici GD; Rojas JC; Rosen HJ; Staffaroni AM; Boeve BF; Dickerson BC; Grossman M; Huey ED; Irwin DJ; Litvan I; Pantelyat AY; Tartaglia MC; Dage JL; Boxer AL JAMA Neurol; 2023 May; 80(5):495-505. PubMed ID: 37010841 [TBL] [Abstract][Full Text] [Related]
3. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy. Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175 [TBL] [Abstract][Full Text] [Related]
4. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445 [TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry-based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways. Jang Y; Thuraisamy T; Redding-Ochoa J; Pletnikova O; Troncoso JC; Rosenthal LS; Dawson TM; Pantelyat AY; Na CH Clin Transl Med; 2022 Nov; 12(11):e1076. PubMed ID: 36354133 [TBL] [Abstract][Full Text] [Related]
6. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. Brendel M; Barthel H; van Eimeren T; Marek K; Beyer L; Song M; Palleis C; Gehmeyr M; Fietzek U; Respondek G; Sauerbeck J; Nitschmann A; Zach C; Hammes J; Barbe MT; Onur O; Jessen F; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Neumaier B; Barret O; Madonia J; Russell DS; Stephens A; Roeber S; Herms J; Bötzel K; Classen J; Bartenstein P; Villemagne V; Levin J; Höglinger GU; Drzezga A; Seibyl J; Sabri O JAMA Neurol; 2020 Nov; 77(11):1408-1419. PubMed ID: 33165511 [TBL] [Abstract][Full Text] [Related]
11. Combined measurement of plasma cystatin C and low-density lipoprotein cholesterol: A valuable tool for evaluating progressive supranuclear palsy. Weng R; Wei X; Yu B; Zhu S; Yang X; Xie F; Zhang M; Jiang Y; Feng ZP; Sun HS; Xia Y; Jin K; Chan P; Wang Q; Gao X Parkinsonism Relat Disord; 2018 Jul; 52():37-42. PubMed ID: 29574085 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007 [TBL] [Abstract][Full Text] [Related]
13. Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial. Tsai RM; Miller Z; Koestler M; Rojas JC; Ljubenkov PA; Rosen HJ; Rabinovici GD; Fagan AM; Cobigo Y; Brown JA; Jung JI; Hare E; Geldmacher DS; Natelson-Love M; McKinley EC; Luong PN; Chuu EL; Powers R; Mumford P; Wolf A; Wang P; Shamloo M; Miller BL; Roberson ED; Boxer AL JAMA Neurol; 2020 Feb; 77(2):215-224. PubMed ID: 31710340 [TBL] [Abstract][Full Text] [Related]
14. Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale. Pantelyat A; Higginbotham L; Rosenthal L; Lanham D; Nesspor V; AlSalihi M; Bang J; Wang J; Albert M Neurodegener Dis; 2020; 20(4):139-146. PubMed ID: 33789283 [TBL] [Abstract][Full Text] [Related]
15. SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease. Weiner S; Sauer M; Brinkmalm G; Constantinescu J; Constantinescu R; Gomes BF; Becker B; Nellgård B; Dalla K; Galasko D; Zetterberg H; Blennow K; Gobom J Alzheimers Dement; 2023 Oct; 19(10):4609-4618. PubMed ID: 36946611 [TBL] [Abstract][Full Text] [Related]
16. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant. Gatto RG; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Dickson DW; Josephs KA; Whitwell JL Neuroimage Clin; 2022; 35():103030. PubMed ID: 35597031 [TBL] [Abstract][Full Text] [Related]
17. Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy. Wagshal D; Sankaranarayanan S; Guss V; Hall T; Berisha F; Lobach I; Karydas A; Voltarelli L; Scherling C; Heuer H; Tartaglia MC; Miller Z; Coppola G; Ahlijanian M; Soares H; Kramer JH; Rabinovici GD; Rosen HJ; Miller BL; Meredith J; Boxer AL J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):244-50. PubMed ID: 24899730 [TBL] [Abstract][Full Text] [Related]
18. Abnormal structural connectivity in progressive supranuclear palsy-Richardson syndrome. Prasad S; Rajan A; Pasha SA; Mangalore S; Saini J; Ingalhalikar M; Pal PK Acta Neurol Scand; 2021 Apr; 143(4):430-440. PubMed ID: 33175396 [TBL] [Abstract][Full Text] [Related]
19. Neurofilament Light Chain Levels in Frontotemporal Dementia and Progressive Supranuclear Palsy: A Systematic Review. Bendstrup N; Hejl AM; Salvesen L J Alzheimers Dis; 2022; 87(1):131-140. PubMed ID: 35275542 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus. Kawamura K; Miyajima M; Nakajima M; Kanai M; Motoi Y; Nojiri S; Akiba C; Ogino I; Xu H; Kamohara C; Yamada S; Karagiozov K; Ikeuchi T; Kondo A; Arai H J Alzheimers Dis; 2021; 83(1):179-190. PubMed ID: 34275898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]